fda warning letter bpc-157 compounding unapproved new drug The U.S. Food and Drug Administration is moving FDA Pharmacy Compounding Committee Votes
Description
However, you dont have to be vegan or vegetarian to develop a deficiency
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist administered as a once-weekly subcutaneous injection

Add 50mg zinc picolinate daily for additional transport support

The FDA label also explicitly states it is not indicated for weight loss management and notes that long-term cardiovascular safety has not been established
